Drugs / Korean Red Ginseng
Korean Red Ginseng
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05592093 | Mar 2023 → Oct 2024 | — | Shanghai Jiao Tong University School of Medicine | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT01664156 | Oct 2012 → Dec 2013 | — | The Korean Society of Ginseng | Completed | No outcome recorded |
| Phase 4 | NCT02204826 | Apr 2011 → Feb 2012 | male infertility | Pusan National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02202382 | Apr 2011 → Jan 2012 | male infertility | Pusan National University Hospital | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02211352 Comparator | May 2012 → Dec 2013 | essential hypertension | Daegu Catholic University Medical Center | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Korean red ginseng | “Korean red ginseng (KRG)” NCT02202382 ↗ |
| Known as | Korean Red Ginseng Powder Capsule | “The patients will receive Korean red ginseng(Korean Red Ginseng Powder Capsule®; Korea Ginseng Corporation, Daejeon, Korea).” NCT01664156 ↗ |
| Known as | KRG | “The purpose of this study is to determine Korean red ginseng (KRG)treatment could decrease central blood pressure in subjects with hypertension.” NCT02211352 ↗3“Korean red ginseng (KRG), which is a steamed form of Panax ginseng” PMID 24354675 ↗ Dec 2013 “Korean Red Ginseng (KRG)” NCT02204826 ↗ “Korean red ginseng (KRG)” NCT02202382 ↗ |
| Known as | red ginseng | “Korean red ginseng capsule (marketed product in Korea) KRGO group and placebo group were used for treatment.” NCT05592093 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “KRG has long been applied to various diseases as a health-promoting herbal medicine in Korea.” NCT02204826 ↗ |
| Route | Oral | “During the administration period, 6 capsules 2 times a day (1h after breakfast and dinner) of Korean red ginseng or its placebo will be provided.” NCT01664156 ↗ |